Iron deficiency, thrombocytosis and thromboembolism;Eisenmangel, Thrombozytose und Thromboembolie

Wiener Medizinische Wochenschrift

Volumn 166, Issue 13-14, 2016, Pages 437-446

  Evstatiev, Rayko ^a  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

Author keywords

Anemia; Iron deficiency; Thrombocytosis; Thromboembolism; Thrombosis

Indexed keywords

IRON;

ARTICLE; CHRONIC KIDNEY DISEASE; HUMAN; INFLAMMATORY BOWEL DISEASE; IRON DEFICIENCY; IRON THERAPY; MALIGNANT NEOPLASTIC DISEASE; RISK FACTOR; THROMBOCYTOSIS; THROMBOEMBOLISM; ADOLESCENT; ADULT; CHILD; COMPLICATION; FEMALE; HEMOGLOBIN DETERMINATION; INFANT; IRON DEFICIENCY ANEMIA; MALE; MIDDLE AGED; PATHOPHYSIOLOGY; PRESCHOOL CHILD; THROMBOSIS; YOUNG ADULT;

ADOLESCENT; ADULT; ANEMIA, IRON-DEFICIENCY; CHILD; CHILD, PRESCHOOL; FEMALE; HEMOGLOBINOMETRY; HUMANS; INFANT; MALE; MIDDLE AGED; RISK FACTORS; THROMBOCYTOSIS; THROMBOEMBOLISM; THROMBOSIS; YOUNG ADULT;

EID: 84988922390     PISSN: 00435341     EISSN: 1563258X     Source Type: Journal    
DOI: 10.1007/s10354-016-0514-6     Document Type: Article

References (131)

1. WHO, UNICEF, UNU. Iron deficiency anemia: assessment, prevention and control 2001. http://whqlibdoc.who.int/hq/2001/WHO_NHD_01.3.pdf. Zugriffen: 12.09.2016
2. Evstatiev R, Gasche C. Iron sensing and signalling. Gut. 2012;61(6):933–52.
3. Yadav D, Chandra J. Iron deficiency: beyond anemia. Indian J Pediatr. 2011;78(1):65–72.
4. Opal SM. Phylogenetic and functional relationships between coagulation and the innate immune response. Crit Care Med. 2000;28(9 Suppl):77–80.
5. Weyrich AS, Lindemann S, Zimmerman GA. The evolving role of platelets in inflammation. J Thromb Haemostasis. 2003;1(9):1897–905.
6. Geddis AE, Fox N, Tkacenko E, Kaushansky K. Endomitotic megakaryocytes that form a bipolar spindle exhibit cleavage furrow ingression followed by furrow regression. Cell Cycle. 2007;6(4):455–60.
7. Lordier L, Jalil A, Aurade F, Larbret F, Larghero J, Debili N, et al. Megakaryocyte endomitosis is a failure of late cytokinesis related to defects in the contractile ring and Rho/Rock signaling. Blood. 2008;112(8):3164–74.
8. Lordier L, Pan J, Naim V, Jalil A, Badirou I, Rameau P, et al. Presence of a defect in karyokinesis during megakaryocyte endomitosis. Cell Cycle. 2012;11(23):4385–9.
9. Ravid K, Lu J, Zimmet JM, Jones MR. Roads to polyploidy: the megakaryocyte example. J Cell Physiol. 2002;190(1):7–20.
10. Evstatiev R, Bukaty A, Jimenez K, Kulnigg-Dabsch S, Surman L, Schmid W, et al. Iron deficiency alters megakaryopoiesis and platelet phenotype independent of thrombopoietin. Am J Hematol. 2014;89(5):524–9.
11. Buss DH, Cashell AW, O’Connor ML, Richards F 2nd, Case LD. Occurrence, etiology, and clinical significance of extreme thrombocytosis: a study of 280 cases. Am J Med. 1994;96(3):247–53.
12. Griesshammer M, Bangerter M, Sauer T, Wennauer R, Bergmann L, Heimpel H. Aetiology and clinical significance of thrombocytosis: analysis of 732 patients with an elevated platelet count. J Intern Med. 1999;245(3):295–300.
13. Schafer AI. Thrombocytosis. N Engl J Med. 2004;350(12):1211–9.
14. Tefferi A, Ho TC, Ahmann GJ, Katzmann JA, Greipp PR. Plasma interleukin-6 and C‑reactive protein levels in reactive versus clonal thrombocytosis. Am J Med. 1994;97(4):374–8.
15. Dan K. Thrombocytosis in iron deficiency anemia. Intern Med. 2005;44(10):1025–6.
16. Gross S, Keefer V, Newman AJ. The platelets in iron-deficiency anemia. I. The responce to oral and parenteral iron. Pediatrics. 1964;34:315–23.
17. Kasper CK, Whissell DY, Wallerstein RO. Clinical aspects of iron deficiency. JAMA. 1965;191:359–63.
18. Keung YK, Owen J. Iron deficiency and thrombosis: literature review. Clin Appl Thromb Hemost. 2004;10(4):387–91.
19. Sandoval C. Thrombocytosis in children with iron deficiency anemia: series of 42 children. J Pediatr Hematol Oncol. 2002;24(7):593.
20. Schloesser LL, Kipp MA, Wenzel FJ. Thrombocytosis in iron deficiency anemia. J Lab Clin Med. 1965;66:107–14.
21. Kulnigg-Dabsch S, Evstatiev R, Dejaco C, Gasche C. Effect of iron therapy on platelet counts in patients with inflammatory bowel disease-associated anemia. PLOS ONE. 2012;7(4):e34520.
22. Kulnigg-Dabsch S, Schmid W, Howaldt S, Stein J, Mickisch O, Waldhor T, et al. Iron deficiency generates secondary thrombocytosis and platelet activation in IBD: the randomized, controlled thromboVIT trial. Inflamm Bowel Dis. 2013;19(8):1609–16, Jul.
23. Kadikoylu G, Yavasoglu I, Bolaman Z, Senturk T. Platelet parameters in women with iron deficiency anemia. J Natl Med Assoc. 2006;98(3):398–402.
24. Choi SI, Simone JV. Platelet production in experimental iron deficiency anemia. Blood. 1973;42(2):219–28.
25. Choi SI, Simone JV, Jackson CW. Megakaryocytopoiesis in experimental iron deficiency anemia. Blood. 1974;43(1):111–20.
26. Garg SK, Weiner M. Thrombocyte and megathrombocyte kinetics during thrombocytosis induced by acute and chronic blood loss and by iron-deficiency diet. Haemostasis. 1972;1(3-4):121.
27. Holter PH, Refsum HE. Postnatal anemia and thrombocytosis in suckling rabbits: influence of delayed weaning and iron supplies. Pediatr Hematol Oncol. 1988;5(3):157–68.
28. Karpatkin S, Garg SK, Freedman ML. Role of iron as a regulator of thrombopoiesis. Am J Med. 1974;57(4):521–5.
29. Kuku I, Kaya E, Yologlu S, Gokdeniz R, Baydin A. Platelet counts in adults with iron deficiency anemia. Platelets. 2009;20(6):401–5.
30. Perlman MK, Schwab JG, Nachman JB, Rubin CM. Thrombocytopenia in children with severe iron deficiency. J Pediatr Hematol Oncol. 2002;24(5):380–4.
31. Park MJ, Park PW, Seo YH, Kim KH, Park SH, Jeong JH, et al. The relationship between iron parameters and platelet parameters in women with iron deficiency anemia and thrombocytosis. Platelets. 2013;24(5):348–51.
32. Akan H, Guven N, Aydogdu I, Arat M, Beksac M, Dalva K. Thrombopoietic cytokines in patients with iron deficiency anemia with or without thrombocytosis. Acta Haematol. 2000;103(3):152–6.
33. Ceresa IF, Noris P, Ambaglio C, Pecci A, Balduini CL. Thrombopoietin is not uniquely responsible for thrombocytosis in inflammatory disorders. Platelets. 2007;18(8):579–82.
34. Papa A, Danese S, Piccirillo N, Toriani-Terenzi C, Bartolozzi F, Piscaglia AC, et al. Thrombopoietin serum levels in patients with inflammatory bowel disease with and without previous thromboembolic events. Hepatogastroenterology. 2003;50(49):132–5.
35. Beguin Y, Loo M, R’Zik S, Sautois B, Lejeune F, Rorive G, et al. Effect of recombinant human erythropoietin on platelets in patients with anemia of renal failure: correlation of platelet count with erythropoietic activity and iron parameters. Eur J Haematol. 1994;53(5):265–70.
36. Broudy VC, Lin NL, Kaushansky K. Thrombopoietin (c-mpl ligand) acts synergistically with erythropoietin, stem cell factor, and interleukin-11 to enhance murine megakaryocyte colony growth and increases megakaryocyte ploidy in vitro. Blood. 1995;85(7):1719–26.
37. Racke FK. EPO and TPO sequences do not explain thrombocytosis in iron deficiency anemia. J Pediatr Hematol Oncol. 2003;25(11):919.
38. Klimchenko O, Mori M, Distefano A, Langlois T, Larbret F, Lecluse Y, et al. A common bipotent progenitor generates the erythroid and megakaryocyte lineages in embryonic stem cell-derived primitive hematopoiesis. Blood. 2009;114(8):1506–17.
39. Bilic E, Bilic E. Amino acid sequence homology of thrombopoietin and erythropoietin may explain thrombocytosis in children with iron deficiency anemia. J Pediatr Hematol Oncol. 2003;25(8):675–6.
40. Geddis AE, Kaushansky K. Cross-reactivity between erythropoietin and thrombopoietin at the level of Mpl does not account for the thrombocytosis seen in iron deficiency. J Pediatr Hematol Oncol. 2003;25(11):919–20.
41. Dahl NV, Henry DH, Coyne DW. Thrombosis with erythropoietic stimulating agents-does iron-deficient erythropoiesis play a role? Semin Dial. 2008;21(3):210–1.
42. Jimenez K, Khare V, Evstatiev R, Kulnigg-Dabsch S, Jambrich M, Strobl H, et al. Increased expression of HIF2alpha during iron deficiency-associated megakaryocytic differentiation. J Thromb Haemostasis. 2015;13(6):1113–27.
43. Robinson KA, O’Donnell ME, Pearson D, Kriegshauser JS, Odeleye M, Kalkbrenner K, et al. Portomesenteric venous thrombosis following major colon and rectal surgery: incidence and risk factors. Surg Endosc. 2015;29(5):1071–9.
44. Schmuziger M, Christenson JT, Maurice J, Simonet F, Velebit V. Reactive thrombocytosis after coronary bypass surgery. An important risk factor. Eur J Cardiothorac Surg. 1995;9(7):393–7, discussion 7–8.
45. Kashuk JL, Moore EE, Johnson JL, Biffl WL, Burlew CC, Barnett C, et al. Progressive postinjury thrombocytosis is associated with thromboembolic complications. Surgery. 2010;148(4):667–74, discussion 74–5.
46. Ho KM, Chavan S. Prevalence of thrombocytosis in critically ill patients and its association with symptomatic acute pulmonary embolism. A multicentre registry study. Thromb Haemost. 2013;109(2):272–9.
47. Ho KM, Yip CB, Duff O. Reactive thrombocytosis and risk of subsequent venous thromboembolism: a cohort study. J Thromb Haemostasis. 2012;10(9):1768–74.
48. Pate A, Baltazar GA, Labana S, Bhagat T, Kim J, Chendrasekhar A. Systemic inflammatory response syndrome and platelet count 〉/=250x10(9) are associated with venous thromboembolic disease. Int J Gen Med. 2015;8:37–40.
49. Khorana AA, Francis CW, Culakova E, Lyman GH. Risk factors for chemotherapy-associated venous thromboembolism in a prospective observational study. Cancer. 2005;104(12):2822–9.
50. Khorana AA, Kuderer NM, Culakova E, Lyman GH, Francis CW. Development and validation of a predictive model for chemotherapy-associated thrombosis. Blood. 2008;111(10):4902–7.
51. Simanek R, Vormittag R, Ay C, Alguel G, Dunkler D, Schwarzinger I, et al. High platelet count associated with venous thromboembolism in cancer patients: results from the Vienna Cancer and Thrombosis Study (CATS). J Thromb Haemost. 2010;8(1):114–20.
52. Cooke NM, Egan K, McFadden S, Grogan L, Breathnach OS, O’Leary J, et al. Increased platelet reactivity in patients with late-stage metastatic cancer. Cancer Med. 2013;2(4):564–70.
53. Duff OC, Ho KM, Maybury SM. In vitro thrombotic tendency of reactive thrombocytosis in critically ill patients: a prospective case-control study. Anaesth Intensive Care. 2012;40(3):472–8.
54. Harr JN, Moore EE, Chin TL, Ghasabyan A, Gonzalez E, Wohlauer MV, et al. Platelets are dominant contributors to hypercoagulability after injury. J Trauma Acute Care Surg. 2013;74(3):756–62, discussion 62–5.
55. Azab SF, Abdelsalam SM, Saleh SH, Elbehedy RM, Lotfy SM, Esh AM, et al. Iron deficiency anemia as a risk factor for cerebrovascular events in early childhood: a case-control study. Ann Hematol. 2014;93(4):571–6.
56. Chang YL, Hung SH, Ling W, Lin HC, Li HC, Chung SD. Association between ischemic stroke and iron-deficiency anemia: a population-based study. PLOS ONE. 2013;8(12):e82952.
57. Dubyk MD, Card RT, Whiting SJ, Boyle CA, Zlotkin SH, Paterson PG. Iron deficiency anemia prevalence at first stroke or transient ischemic attack. Can J Neurol Sci. 2012;39(2):189–95.
58. Gillum RF, Sempos CT, Makuc DM, Looker AC, Chien CY, Ingram DD. Serum transferrin saturation, stroke incidence, and mortality in women and men. The NHANES I epidemiologic followup study. National Health and Nutrition Examination Survey. Am J Epidemiol. 1996;144(1):59–68.
59. Katsanos AH, Kosmidou M, Giannopoulos S, Katsanos KH, Tsivgoulis G, Kyritsis AP, et al. Cerebral arterial infarction in inflammatory bowel diseases. Eur J Intern Med. 2014;25(1):37–44.
60. Hung SH, Lin HC, Chung SD. Association between venous thromboembolism and iron-deficiency anemia: a population-based study. Blood Coagul Fibrinolysis. 2015;26(4):368–72.
61. Potaczek DP, Jankowska EA, Wypasek E, Undas A. Iron deficiency: a novel risk factor of recurrence in patients after unprovoked venous thromboembolism. Pol Arch Med Wewn. 2016;126 doi:10.20452/pamw.3311.
62. Stolz E, Valdueza JM, Grebe M, Schlachetzki F, Schmitt E, Madlener K, et al. Anemia as a risk factor for cerebral venous thrombosis? An old hypothesis revisited. Results of a prospective study. J Neurol. 2007;254(6):729–34.
63. Grainge MJ, West J, Card TR. Venous thromboembolism during active disease and remission in inflammatory bowel disease: a cohort study. Lancet. 2010;375(9715):657–63.
64. Miehsler W, Reinisch W, Valic E, Osterode W, Tillinger W, Feichtenschlager T, et al. Is inflammatory bowel disease an independent and disease specific risk factor for thromboembolism? Gut. 2004;53(4):542–8.
65. Novacek G, Weltermann A, Sobala A, Tilg H, Petritsch W, Reinisch W, et al. Inflammatory bowel disease is a risk factor for recurrent venous thromboembolism. Gastroenterology. 2010;139(3):779–87, 787 e1.
66. Filmann N, Rey J, Schneeweiss S, Ardizzone S, Bager P, Bergamaschi G, et al. Prevalence of anemia in inflammatory bowel diseases in european countries: a systematic review and individual patient data meta-analysis. Inflamm Bowel Dis. 2014;20(5):936–45.
67. Kulnigg S, Gasche C. Systematic review: managing anaemia in Crohn’s disease. Aliment Pharmacol Ther. 2006;24(11–12):1507–23.
68. Harries AD, Fitzsimons E, Fifield R, Dew MJ, Rhoades J. Platelet count: a simple measure of activity in Crohn’s disease. Br Med J. 1983;286(6376):1476.
69. Talstad I, Rootwelt K, Gjone E. Thrombocytosis in ulcerative colitis and Crohn’s disease. Scand J Gastroenterol. 1973;8(2):135–8.
70. Heits F, Stahl M, Ludwig D, Stange EF, Jelkmann W. Elevated serum thrombopoietin and interleukin-6 concentrations in thrombocytosis associated with inflammatory bowel disease. J Interferon Cytokine Res. 1999;19(7):757–60.
71. Voudoukis E, Karmiris K, Oustamanolakis P, Theodoropoulou A, Sfiridaki A, Paspatis GA, et al. Association between thrombocytosis and iron deficiency anemia in inflammatory bowel disease. Eur J Gastroenterol Hepatol. 2013; doi:10.1097/meg.0b013e328363e354.
72. Webberley MJ, Hart MT, Melikian V. Thromboembolism in inflammatory bowel disease: role of platelets. Gut. 1993;34(2):247–51.
73. Besarab A, Bolton WK, Browne JK, Egrie JC, Nissenson AR, Okamoto DM, et al. The effects of normal as compared with low hematocrit values in patients with cardiac disease who are receiving hemodialysis and epoetin. N Engl J Med. 1998;339(9):584–90.
74. Drueke TB, Locatelli F, Clyne N, Eckardt KU, Macdougall IC, Tsakiris D, et al. Normalization of hemoglobin level in patients with chronic kidney disease and anemia. N Engl J Med. 2006;355(20):2071–84.
75. Phrommintikul A, Haas SJ, Elsik M, Krum H. Mortality and target haemoglobin concentrations in anaemic patients with chronic kidney disease treated with erythropoietin: a meta-analysis. Lancet. 2007;369(9559):381–8.
76. Singh AK, Szczech L, Tang KL, Barnhart H, Sapp S, Wolfson M, et al. Correction of anemia with epoetin alfa in chronic kidney disease. N Engl J Med. 2006;355(20):2085–98.
77. Macdougall IC, Bircher AJ, Eckardt KU, Obrador GT, Pollock CA, Stenvinkel P, et al. Iron management in chronic kidney disease: conclusions from a ”Kidney Disease: Improving Global Outcomes“ (KDIGO) Controversies Conference. Kidney Int. 2016;89(1):28–39.
78. Macdougall IC, Bock AH, Carrera F, Eckardt KU, Gaillard C, van Wyck D, et al. FIND-CKD: a randomized trial of intravenous ferric carboxymaltose versus oral iron in patients with chronic kidney disease and iron deficiency anaemia. Nephrol Dial Transplant. 2014;29(11):2075–84.
79. Coyne DW, Kapoian T, Suki W, Singh AK, Moran JE, Dahl NV, et al. Ferric gluconate is highly efficacious in anemic hemodialysis patients with high serum ferritin and low transferrin saturation: results of the Dialysis Patients’ Response to IV Iron with Elevated Ferritin (DRIVE) Study. J Am Soc Nephrol. 2007;18(3):975–84.
80. Beguin Y. Erythropoietin and platelet production. Haematologica. 1999;84(6):541–7.
81. Loo M, Beguin Y. The effect of recombinant human erythropoietin on platelet counts is strongly modulated by the adequacy of iron supply. Blood. 1999;93(10):3286–93.
82. Kalantar-Zadeh K, McAllister CJ, Lehn RS, Liu E, Kopple JD. A low serum iron level is a predictor of poor outcome in hemodialysis patients. Am J Kidney Dis. 2004;43(4):671–84.
83. Kalantar-Zadeh K, Regidor DL, McAllister CJ, Michael B, Warnock DG. Time-dependent associations between iron and mortality in hemodialysis patients. J Am Soc Nephrol. 2005;16(10):3070–80.
84. Besarab A, Horl WH, Silverberg D. Iron metabolism, iron deficiency, thrombocytosis, and the cardiorenal anemia syndrome. Oncologist. 2009;14(Suppl 1):22–33.
85. Streja E, Kovesdy CP, Greenland S, Kopple JD, McAllister CJ, Nissenson AR, et al. Erythropoietin, iron depletion, and relative thrombocytosis: a possible explanation for hemoglobin-survival paradox in hemodialysis. Am J Kidney Dis. 2008;52(4):727–36.
86. Konigsbrugge O, Pabinger I, Ay C. Risk factors for venous thromboembolism in cancer: novel findings from the Vienna Cancer and Thrombosis Study (CATS). Thromb Res. 2014;133(Suppl 2):39–43.
87. Ay C, Dunkler D, Marosi C, Chiriac AL, Vormittag R, Simanek R, et al. Prediction of venous thromboembolism in cancer patients. Blood. 2010;116(24):5377–82.
88. Ludwig H, Muldur E, Endler G, Hubl W. Prevalence of iron deficiency across different tumors and its association with poor performance status, disease status and anemia. Ann Oncol. 2013;24(7):1886–92.
89. Rizzo JD, Brouwers M, Hurley P, Seidenfeld J, Somerfield MR, Temin S. American society of clinical oncology/american society of hematology clinical practice guideline update on the use of epoetin and darbepoetin in adult patients with cancer. J Oncol Pract. 2010;6(6):317–20.
90. Schrijvers D, De Samblanx H, Roila F, Group EGW. Erythropoiesis-stimulating agents in the treatment of anaemia in cancer patients: ESMO Clinical Practice Guidelines for use. Ann Oncol. 2010;21(Suppl 5):v244–v247.
91. Bohlius J, Wilson J, Seidenfeld J, Piper M, Schwarzer G, Sandercock J, et al. Recombinant human erythropoietins and cancer patients: updated meta-analysis of 57 studies including 9353 patients. J Natl Cancer Inst. 2006;98(10):708–14.
92. Auerbach M, Ballard H, Trout JR, McIlwain M, Ackerman A, Bahrain H, et al. Intravenous iron optimizes the response to recombinant human erythropoietin in cancer patients with chemotherapy-related anemia: a multicenter, open-label, randomized trial. J Clin Oncol. 2004;22(7):1301–7.
93. Henry DH, Dahl NV, Auerbach M, Tchekmedyian S, Laufman LR. Intravenous ferric gluconate significantly improves response to epoetin alfa versus oral iron or no iron in anemic patients with cancer receiving chemotherapy. Oncologist. 2007;12(2):231–42.
94. Henry DH, Dahl NV, Auerbach MA. Thrombocytosis and venous thromboembolism in cancer patients with chemotherapy induced anemia may be related to ESA induced iron restricted erythropoiesis and reversed by administration of IV iron. Am J Hematol. 2012;87(3):308–10.
95. Knizley H Jr., Noyes WD. Iron deficiency anemia, papilledema, thrombocytosis, and transient hemiparesis. Arch Intern Med. 1972;129(3):483–6.
96. Alexander MB. Iron deficiency anemia, thrombocytosis, and cerebrovascular accident. South Med J. 1983;76(5):662–3.
97. Heller DS, Pervez NK, Kleinerman J. Fatal cerebrovascular thrombosis in a young woman: an unusual complication associated with hypochromic anemia and thrombocytosis following surgery. Mt Sinai J Med. 1988;55(4):318–20.
98. Ready WK, Lowry NJ. Anemia causing cerebral infarction in a child. Can Med Assoc J. 1989;140(3):303–4.
99. Aoki N, Sakai T. Cerebral sinus thrombosis in patients with severe iron deficiency anaemia due to myoma uteri. Acta Neurochir (Wien). 1989;97(3–4):131–4.
100. Bruggers CS, Ware R, Altman AJ, Rourk MH, Vedanarayanan V, Chaffee S. Reversible focal neurologic deficits in severe iron deficiency anemia. J Pediatr. 1990;117(3):430–2.
101. Saxena VK, Brands C, Crols R, Moens E, Marien P, de Deyn PP. Multiple cerebral infarctions in a young patient with secondary thrombocythemia due to iron deficiency anemia. Acta Neurol (Napoli). 1993;15(4):297–302.
102. Akins PT, Glenn S, Nemeth PM, Derdeyn CP. Carotid artery thrombus associated with severe iron-deficiency anemia and thrombocytosis. Stroke. 1996;27(5):1002–5.
103. Matsuoka Y, Hayasaka S, Yamada K. Incomplete occlusion of central retinal artery in a girl with iron deficiency anemia. Ophthalmol J Int. 1996;210(6):358–60.
104. Hartfield DS, Lowry NJ, Keene DL, Yager JY. Iron deficiency: a cause of stroke in infants and children. Pediatr Neurol. 1997;16(1):50–3.
105. Swann IL, Kendra JR. Severe iron deficiency anaemia and stroke. Clin Lab Haematol. 2000;22(4):221–3.
106. Kacer B, Hattenbach LO, Horle S, Scharrer I, Kroll P, Koch F. Central retinal vein occlusion and nonarteritic ischemic optic neuropathy in 2 patients with mild iron deficiency anemia. Ophthalmol J Int. 2001;215(2):128–31.
107. Standridge S, de los Reyes E. Inflammatory bowel disease and cerebrovascular arterial and venous thromboembolic events in 4 pediatric patients: a case series and review of the literature. J Child Neurol. 2008;23(1):59–66.
108. Williams B, Morton C. Cerebral vascular accident in a patient with reactive thrombocytosis: a rare cause of stroke. Am J Med Sci. 2008;336(3):279–81.
109. Wiesen JA, Kurtz LE, Katz S. Widespread occlusive vascular disease in a Crohn’s disease patient with profound thrombocytosis. J Clin Gastroenterol. 2006;40(9):863–4.
110. Bukharovich IF, Wever-Pinzon O, Shah A, Todd G, Chaudhry FA, Sherrid MV. Arterial embolism caused by large mobile aortic thrombus in the absence of atherosclerosis, associated with iron deficiency anemia. Echocardiography. 2012;29(3):369–72.
111. Batur Caglayan HZ, Nazliel B, Irkec C, Dumlu A, Filiz A, Panpalli Ates M. Iron-deficiency anemia leading to transient ischemic attacks due to Intraluminal carotid artery thrombus. Case Rep Neurol Med. 2013;2013:813415. doi:10.1155/2013/813415.
112. Naito H, Naka H, Kanaya Y, Yamazaki Y, Tokinobu H. Two cases of acute ischemic stroke associated with iron deficiency anemia due to bleeding from uterine fibroids in middle-aged women. Intern Med. 2014;53(21):2533–7.
113. Kirkham TH, Wrigley PF, Holt JM. Central retinal vein occlusion complicating iron deficiency anaemia. Br J Ophthalmol. 1971;55(11):777–80.
114. Belman AL, Roque CT, Ancona R, Anand AK, Davis RP. Cerebral venous thrombosis in a child with iron deficiency anemia and thrombocytosis. Stroke. 1990;21(3):488–93.
115. Shibuya Y, Hayasaka S. Central retinal vein occlusion in a patient with anorexia nervosa. Am J Ophthalmol. 1995;119(1):109–10.
116. Meena AK, Naidu KS, Murthy JM. Cortical sinovenous thrombosis in a child with nephrotic syndrome and iron deficiency anaemia. Neurol India. 2000;48(3):292–4.
117. Benedict SL, Bonkowsky JL, Thompson JA, van Orman CB, Boyer RS, Bale JF Jr., et al. Cerebral sinovenous thrombosis in children: another reason to treat iron deficiency anemia. J Child Neurol. 2004;19(7):526–31.
118. Kinoshita Y, Taniura S, Shishido H, Nojima T, Kamitani H, Watanebe T. Cerebral venous sinus thrombosis associated with iron deficiency: two case reports. Neurol Med Chir (Tokyo). 2006;46(12):589–93.
119. Balci K, Utku U, Asil T, Buyukkoyuncu N. Deep cerebral vein thrombosis associated with iron deficiency anaemia in adults. J Clin Neurosci. 2007;14(2):181–4.
120. Ogata T, Kamouchi M, Kitazono T, Kuroda J, Ooboshi H, Shono T, et al. Cerebral venous thrombosis associated with iron deficiency anemia. J Stroke Cerebrovasc Dis. 2008;17(6):426–8.
121. Habis A, Hobson WL, Greenberg R. Cerebral sinovenous thrombosis in a toddler with iron deficiency anemia. Pediatr Emerg Care. 2010;26(11):848–51.
122. Nicastro N, Schnider A, Leemann B. Iron-deficiency anemia as a rare cause of cerebral venous thrombosis and pulmonary embolism. Case Rep Med. 2012;2012:497814. doi:10.1155/2012/497814.
123. Beri S, Khan A, Hussain N, Gosalakkal J. Severe anemia causing cerebral venous sinus thrombosis in an infant. J Pediatr Neurosci. 2012;7(1):30–2.
124. Zhu XQ, Cao L. Cerebral venous sinus thrombosis following diagnostic curettage in a patient with uterine fibroid. Case Rep Neurol Med. 2014;2014:270654. doi:10.1155/2014/270654.
125. Nishioka K, Tanaka R, Tsutsumi S, Yamashiro K, Nakahara M, Shimura H, et al. Cerebral dural sinus thrombosis associated with adenomyosis: a case report. J Stroke Cerebrovasc Dis. 2014;23(7):1985–7.
126. Corrales-Medina FF, Grant L, Egas-Bejar D, Valdivia-Ascuna Z, Rodriguez N, Mancias P. Cerebral sinovenous thrombosis associated with iron deficiency anemia secondary to severe menorrhagia: a case report. J Child Neurol. 2014;29(9):NP62–NP64.
127. Choe Y, Lee JB, Kim YJ, Choi IS. Cerebral venous sinus thrombosis and venous hemorrhagic infarction in a young woman. Ann Rehabil Med. 2014;38(5):698–701.
128. Finkel L, Piantino J, Goldstein J, Wainwright MS. Venous stroke and status epilepticus due to milk-induced anemia in a child. Pediatr Emerg Care. 2015;31(2):129–31, Feb.
129. Perlman MK, Schwab JG, Nachman JB, Rubin CM. Thrombocytopenia in children with severe iron deficiency. J Pediatr Hematol Oncol. 2002 6/2002;24(5):380–4.
130. Sladic-Simic D, Martinovitch PN, Zivkovic N, Pavic D, Martinovic J, Kahn M, et al. A thalassemia-like disorder in Belgrade laboratory rats. Annals of the New York Academy of Sciences. 1969 Nov 20;165(1):93–9.
131. Du X, She E, Gelbart T, Truksa J, Lee P, Xia Y, et al. The serine protease TMPRSS6 is required to sense iron deficiency. Science. 2008 May 23;320(5879):1088–92.